|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.76 USD | -5.95% |
|
+7.76% | -4.55% |
| Jul. 30 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| Jul. 28 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 40.89 | 40.89 | 42.38 |
| Spread/Res. | -7.65% | -7.65% | -10.90% |
| Spread/Supp. | +14.42% | +14.42% | +43.68% |
| Support | 33 | 33 | 26.28 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ATRC Stock
- Charts AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
